Hope Medicine
Innovation for Life, Beyond Borders

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. For more details about cookies and how to manage them see our Privacy Policy.

pc-2.jpg

Hope Medicine
Innovation for Life, Beyond Borders

A science-driven biotech with mission to develop innovative medicines to improve patients' life

banner.jpg

Hope Medicine
Innovation for Life, Beyond Borders

Nanjing Biological R&D Center

tuceng8.png

Hope Medicine
Innovation for Life, Beyond Borders

HopeMed-PKU Joint Lab

About Hope Medicine

Hope Medicine (HopeMed) is a science-driven, patient-centric, clinical-stage biotech company with research and development bases in major innovation hubs in China. The company was established on the foundation of deep understanding of disease biology and translational medicine, and decades of scientific research in the laboratory of the founder, Professor Rui-Ping Xiao, at Peking University. With a management team of highly accomplished industry veterans combining entrepreneurship and global pharma experience, HopeMed is committed to the discovery, development, and commercialization of innovative, safe, effective, affordable medicines for large, underserved patient populations. Strategically, we are building a robust pipeline in the field of endocrine, cardiovascular and metabolic diseases, with a special focus on women’s health, through internal R&D capabilities, access to external technology platforms to enable a variety of molecular modalities, as well as in-license of complementary and differentiated assets to address unmet medical needs.

a_bg1.png

Follow Us

g_img1.png

Top